BECK MACK & OLIVER LLC TEVA TEVA PHARMAC.IND.ADR COM

Ownership history in BECK MACK & OLIVER LLC  ·  62 quarters on record

AI Ownership Summary

BECK MACK & OLIVER LLC reported TEVA PHARMAC.IND.ADR COM (TEVA) in 62 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 0.65% in 2026 Q1. The latest visible filing shows TEVA at 0.65% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this TEVA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was BECK MACK & OLIVER LLC's position in TEVA PHARMAC.IND.ADR COM, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

TEVA was reported at 0.65% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.65% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How BECK MACK & OLIVER LLC held TEVA — position size vs. price
% of Fund (quarterly)    TEVA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 1,051,700 -4,800 -0.5% 0.65% $31.7M 2026-05-12 $35.81
2025 Q4 REDUCED 1,056,500 -40,480 -3.7% 0.60% $33.0M 2026-02-12 $33.92
2025 Q3 REDUCED 1,096,980 -2,005 -0.2% 0.40% $22.2M 2025-11-14 $25.41
2025 Q2 REDUCED 6.1% +14.4% 1,098,985 -71,750 -6.1% 0.35% $18.4M 2025-08-14 $17.54
2025 Q1 REDUCED 1,170,735 -26,755 -2.2% 0.36% $18.0M 2025-05-15 $16.87
2024 Q4 REDUCED 1,197,490 -36,160 -2.9% 0.49% $26.4M 2025-02-13 $16.63
2024 Q3 REDUCED 5.6% +23.9% 1,233,650 -73,650 -5.6% 0.43% $22.2M 2024-11-13 $16.94
2024 Q2 REDUCED 31.0% +10.9% 1,307,300 -586,191 -31.0% 0.44% $21.2M 2024-08-14 $18.01
2024 Q1 REDUCED 22.1% +15.8% 1,893,491 -538,723 -22.1% 0.54% $26.7M 2024-05-14 $17.09
2023 Q4 REDUCED 23.4% +33.2% 2,432,214 -744,898 -23.4% 0.59% $25.4M 2024-02-14 $13.17
52 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About BECK MACK & OLIVER LLC and TEVA

These are the practical questions this page is built to answer before you even open the full history table.

How long has BECK MACK & OLIVER LLC reported owning TEVA?

BECK MACK & OLIVER LLC reported TEVA across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported TEVA position in BECK MACK & OLIVER LLC's portfolio?

The largest reported portfolio weight for TEVA was 0.65% in 2026 Q1.

What is the latest reported TEVA position on this page?

The most recent filing on this page is 2026 Q1, when BECK MACK & OLIVER LLC reported 1,051,700 shares, equal to 0.65% of portfolio, with an estimated market value of $31.7M.

What does the chart on this TEVA ownership page compare?

The chart compares BECK MACK & OLIVER LLC's quarterly TEVA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did BECK MACK & OLIVER LLC time their TEVA position?

Based on 13F filing dates vs. subsequent TEVA price moves, BECK MACK & OLIVER LLC correctly timed 22 out of 52 reported position changes (42%). The annualised alpha on TEVA relative to SPY over the holding period was -8.3%.

← Back to BECK MACK & OLIVER LLC Holdings